Advertisment

Odisha Health Minister Naba Das succumbs to bullet injuries

author-image
Shefali Kohli
New Update
Odisha Health Minister Naba Das succumbs to bullet injuries
Advertisment

Odisha, January 29:  As per the officials, Odisha Health Minister Naba Das, who was shot at in Brajarajnagar in the Jharsuguda district, succumbed to his bullet injuries in Bhubaneswar.

Advertisment

 The Minister, who was said to be in a critical condition, was airlifted to the Apollo Hospital in Bhubaneswar where he breathed his last.

Advertisment

 Das was shot at by one police personnel near Brajarajnagar in Jharsuguda district earlier today, following which he was critically injured.

 A team of doctors led by Dr Debashish Nayak immediately attended to and operated on him.

 On operating was found that a single bullet had entered and exited the body, injuring the heart and left lung and causing massive internal bleeding and injury, the officials said.

Advertisment

 The injuries were repaired, and steps were taken to improve the pumping of the heart. He was given urgent ICU care. But despite the best of efforts, he could not be revived and succumbed to his injuries.



 In the meanwhile, Chief Minister Naveen Patnaik expressed deep shock and distress over the unfortunate death of Minister Naba Das.

Advertisment

The Chief Minister also directed the Crime Branch to take up the investigation into the matter, following which a team of Odisha Crime Branch headed by a senior police official proceeded to Brajarajnagar where state Health Minister Naba Das was shot at.

The incident occurred at about 12.30 afternoon at Gandhi chowk when Das was on his way to attend a programme. He sustained bullet injuries to his left chest, leaving him seriously injured. 

 Also Read | PM Narendra Modi to hold first 'Mann Ki Baat' of 2023 at 11 am

Advertisment

The exact reason behind the firing is still unclear. 

  



- ANI
odisha-health-minister naba-das-succumbs-bullet-injuries naba-das-shot
Advertisment

Stay updated with the latest news headlines.

Follow us:
Advertisment